Spots Global Cancer Trial Database for Cardiovascular Morbidities and Lung Cancer Treatment: a Prospective Registry
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Cardiovascular Morbidities and Lung Cancer Treatment: a Prospective Registry
Official Title: Cardiovascular Morbidities and Lung Cancer Treatment
Study ID: NCT03368820
Conditions
Interventions
Study Description
Brief Summary: Therapeutic algorithms for lung cancer are mainly based on randomised controlled trials which excluded patients with severe co-morbidities. Smoking, the main risk factor for lung cancer, is associated with cardiovascular events that may impact on the therapeutic decision. The aim of this registry is to determine if and how cardiovascular co-morbidities impact on the physicians' decision for anticancer treatment in lung cancer patients by comparing it to the European Lung Cancer Working Party (ELCWP) guidelines
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, , Belgium
Hôpital Saint-Joseph, Charleroi, , Belgium
CHU Tivoli, La Louvière, , Belgium
Hôpital Ambroise Paré, Mons, , Belgium
CH Peltzer-La Tourelle, Verviers, , Belgium
Hôpital Mont-Godinne, Yvoir, , Belgium
Contact Details
Name: Thierry Berghmans, MD, PhD
Affiliation: ELCWP
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
